Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.
Ocugen has announced the publication of positive results from its phase 1 GARDian1 trial of OCU410ST, a gene therapy for ...
We built TheraTrack to make therapy feel even clearer and more supportive. With simple visual tools, clients and clinicians can stay aligned and make informed decisions together throughout care.” — ...
Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...
The Brighterside of News on MSN
Tiny eye implant could restore vision lost to macular degeneration
In advanced dry disease, a key problem is failure of retinal pigment epithelium, often shortened to RPE. These cells help ...
The study found significant intra-group CMT reductions in the DEX-I group, with a higher percentage reduction than the ...
Idaho families face new Medicaid therapy caps and fear worse is coming after Gov. Little proposed eliminating speech, ...
Acanthamoeba keratitis (AK) is a rare but devastating eye infection caused by a free-living amoeba found in water and soil.
AI diagnostics, wearable health monitors, and digital health devices showcased at CES 2026 signal a major shift toward ...
Moorfields hospital in London is the world's first dedicated clinic for the disorder and seven out of eight patients given ...
Active Chiropractic has added a Styku scanner to its range of diagnostic tools, enabling patients to receive detailed 3D body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results